Wednesday, 21 Aug 2019

Autoimmune/Lupus

Date Typesort ascending Title Save
15 Jun 2018 Social RT @DrAiLynTan: #Visual loss in Giant Cell Arteritis - points to consider via Salvarani #Eular2018 #GCA #vasculitis #blind #blindness #gl…
30 Apr 2017 Social RT @DrRachelTate: Current secondary thrombosis prevention targets for INR. Dr. Erkan @RheumNow #SOTA2017 https://t.co/zGKLxMLa3Q
06 Nov 2017 Social RT @CCalabreseDO: #1173 rheumatic irAEs more common w/combo anti-PD-1/CTLA-4 and assoc w/response to cancer Tx @RheumNow @HealioRheum #ACR1…
26 Oct 2018 Social RT @Rheumforall: Remember cutaneous lupus can be caused by medication. This changes our treatment. https://t.co/UQZE65aOFk
09 Mar 2017 Social IgG4 related Skin Dz:red/itchy plaques, subcut nodules/papules, Pso-like lesions,Palp purpura, urticarial vasculitis https://t.co/tsD1m3cvpK
10 Jun 2015 Social Classification of inflamm aortitis based infiltration patterns seen in GCA, Takayasus, GPA, RA, Sarcoid, AS, infx http://t.co/n75S0FSZ9c
28 Mar 2018 Social Ablynx announced that its drug vobarilizumab (anti-IL-6R nanobody) failed to meet its primary endpoint of dose response in a phase II SLE trial. https://t.co/9Zaw10FFJS
04 Feb 2016 Social Majority of pediatric lupus w/ acute pancreatitis develop macrophage activation syndr w/ high mortality rate https://t.co/CmT3Gsb4a7
08 May 2017 Social EUSTAR Study: Scleroderma pts w/ RNA polymerase III Abs have higher risk of cancer (OR 7.38), esp w/ age & more skin https://t.co/qMZggLHxOX
06 Nov 2017 Social RT @psufka: Great work! Shrinking lung syndrome in lupus is condition we should all be aware of to have on our differential. #ACR17 @rheumn…
17 Sep 2017 Social RheumNow Wk in Review on SLE + metabolic syndr, bisphosphonate holidays, 2 biologies of vasculitis, wonders of Vit D https://t.co/Eop4eziGfw
12 May 2016 Social Retrospective study from Brigham shows adverse SLE pregnancy outcomes assoc. w/ nephritis, cytopenia, serositis https://t.co/SYYTZQEbC2
22 Aug 2016 Social Since FDA approval 2011, Benlystas uptake has been slow, but had $265 million in worldwide sales in 2014. https://t.co/hqViTE0PEs
13 Sep 2015 Social RT @SjogrensCa: Immune Components of Liver Damage Associated with Connective Tissue Diseases http://t.co/z5XlKc6TCA #sjogrens #rheum
15 Dec 2018 Social Bing Bingham MD talking on immune related adverse events (MSK and autoimmune). Says these occur in 3-5% of cancer pts treated with Checkpoint inhibitors. Unofficial surveys show nearly 50% of Rheums have seen these referrals. #MARS #ARTHROS https://t.co/yZHMQjpMz8
17 Jun 2019 Social Dr. Dinesh Khanna discusses the pulmonary outcomes of tocilizumab is systemic sclerosis (focuSSed trial). #EULAR2019 OP0245 https://t.co/KvxoPhvyS6
03 Jul 2015 Social NEJM reviews Jaccouds arthritis in lupus - reducible finger deformities, despite being seronegative for RF/CCP http://t.co/MZJyjnofIG
02 Apr 2019 Social RT @MedReuma: Biologic Treatment of Giant Cell Arteritis. Paul Monach in #RNL2019 #vasculitis @RheumNow https://t.co/2iahcf1Vwp
07 Nov 2017 Social RT @philipcrobinson: Treatment of Sicca Syndrome of immune related adverse events to checkpoint inhibitors @RheumNow #ACR17 https://t.co/l0…
08 Aug 2018 Social Using HCQ levels and Pt Surveys to define adherence, Intl study of 305 SLE pts shows 18.4% of patients as severely nonadherent & 23.4% of patients as nonadherent. There was moderate agreement between questionnaires, drug level, and physician assessment https://t.co/X1HSQc1S8b